logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
X

Xavier Leleu

University of Poitiers

93H指数
1.2K论文数
4.2W被引数
收录论文 174
发表时间
logo
Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis达拉妥木单抗、来那度胺和地塞米松在移植不适宜的新诊断多发性骨髓瘤中的应用：MAIA最终生存分析
errLeukemia
IF13.4
err2026-08-24
err0
errOAAI
errThierry Facon; Shaji K. Kumar; Robert Z. Orlowski; Nizar Bahlis; Philippe Moreau; Hartmut Goldschmidt; Supratik Basu; Cyrille Hulin; Sonja Zweegman; Katja Weisel; Aurore Perrot; Caroline Jacquet; Noopur Raje; Salomon Manier; Ajai Chari; Markus Hansson; Mohamad Mohty; Michel Delforge; Torben Plesner; Gordon Cook; Xavier Leleu; Hang Quach; Christopher P. Venner; Mourad Tiab; Margaret Macro; Laurent Frenzel; George Wang; Huiling Pei; Kasey Bolyard; Robin Carson; Fredrik Borgsten; Saad Z. Usmani
err分享
err收藏
Clinical outcomes of newly diagnosed myeloma patients with SLIM criteria : a subgroup analysis of the CASSIOPEIA study新诊断多发性骨髓瘤患者SLIM标准下的临床结局：CASSIOPEIA研究中的亚组分析
errLeukemia
IF13.4
err2026-08-13
err0
PREAI
errCyrille Touzeau; Aurore Perrot; Cyrille Hulin; Mammoun Dib; Gedeon Agbetsivi; Laure Vincent; Thierry Facon; Xavier Leleu; Niels W.C.J. van de Donk; Annemiek Broijl; Sonja Zweegman; Michel Delforge; Jill Corre; Pieter Sonneveld; Ariane Boumendil; Philippe Moreau
err分享
err收藏
Response profile and long-term outcomes in Cyclin D1-overexpressing multiple myeloma: insights from the CASSIOPEIA trialCyclin D1过表达多发性骨髓瘤的反应特征和长期结局：来自CASSIOPEIA试验的见解
errBlood Cancer Journal
IF11.6
err2026-07-03
err0
errOAAI
errAurore Perrot; Cyrille Touzeau; Stéphane Minvielle; Cyrille Hulin; Denis Caillot; Salomon Manier; Xavier Leleu; Cécile Sonntag; Karim Belhadj; Bertrand Arnulf; Thomas Chalopin; Jean-Richard Eveillard; Martine Escoffre-Barbe; Lionel Karlin; Laure Vincent; Margaret Macro; Hervé Avet-Loiseau; Soraya Wuilleme; Ariane Boumendil; Jill Corre; Philippe Moreau
err分享
err收藏
Infections in Patients Receiving Daratumumab for Newly Diagnosed Multiple Myeloma: A Pooled Analysis of MAIA and ALCYONE达拉妥单抗治疗新诊断多发性骨髓瘤患者的感染：MAIA和ALCYONE研究的合并分析
errBlood Advances
IF7.1
err2026-05-07
err0
errOAAI
errNizar Bahlis; Thierry Facon; Jesus San-Miguel; Saad Z. Usmani; Meletios A. Dimopoulos; Philippe Moreau; Sonja Zweegman; Aurore Perrot; Salomon Manier; Ajai Chari; Noopur Raje; Robert Z. Orlowski; Hartmut Goldschmidt; Supratik Basu; Cyrille Hulin; Katja Weisel; Mohamad Mohty; Xavier Leleu; Torben Plesner; Andrzej Jakubowiak
err分享
err收藏
FDG-PET Medullary Total Tumor Volume Highlights High-Risk Newly Diagnosed Multiple Myeloma Patients in CASSIOPEIA TrialFDG-PET骨髓总肿瘤体积在CASSIOPEIA试验中凸显高风险新诊断多发性骨髓瘤患者
errBlood Advances
IF7.1
err2026-03-31
err0
errOAAI
errBastien Jamet; Shamimeh Ahrari; Sonja Zweegman; Aurore Perrot; Cyrille Hulin; Denis Caillot; Thierry Facon; Xavier Leleu; Karim Belhadj; Emmanuel Itti; Lionel Karlin; Clément Bailly; Mark-David Levin; Monique C. Minnema; Caroline Bodet-Milin; Bart de Keizer; Jill Corre; Pieter Sonneveld; Diana Mateus; Philippe Moreau
err分享
err收藏
Isatuximab, bortezomib, lenalidomide, dexamethasone for multiple myeloma: Dynamics of MRD-negativity in the IMROZ studyIsatuximab，bortezomib，lenalidomide，dexamethasone用于多发性骨髓瘤：IMROZ研究中MRD阴性的动态变化
errBlood
IF23.1
err2026-03-03
err0
errOAAI
errRobert Z. Orlowski; Meletios A. Dimopoulos; Xavier Leleu; Thierry Facon; Tadao Ishida; Roman Hájek; Ivan Špička; Joanna Romejko-Jarosinska; Vladimir Vorobyev; Britta Besemer; Sevgi Kalayoglu Besisik; Pawel Robak; Tomas Jelinek; Hartmut Goldschmidt; Thomas Martin; Mohamad Mohty; Sandrine Macé; Ercem Kodas; Christina Tekle; Andrea T. Shafer
err分享
err收藏
Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trialCilta-cel 在来那度胺难治性多发性骨髓瘤中的疗效（CARTITUDE-4）：一项开放标签、多中心、随机、III期试验的更新分析，包括总生存期数据
errThe Lancet Oncology
IF0
err2026-01-07
err0
errOAAI
errHermann Einsele; Jesús San-Miguel; Binod Dhakal; Cyrille Touzeau; Xavier Leleu; Niels WCJ van de Donk; Surbhi Sidana; Albert Oriol; Yael C Cohen; Simon J Harrison; María-Victoria Mateos; Joaquín Martínez-López; Paolo Corradini; Lionel Karlin; Diana Chen; Quanlin Li; Tzu-min Yeh; Katherine Li; Vicki Plaks; Ana Slaughter
err分享
err收藏
35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience35年专注于高剂量疗法和自体干细胞移植的学术研究：法国骨髓瘤研究组(IFM)的经验
errBlood Cancer Journal
IF11.6
err2025-10-24
err0
errOAAI
errPhilippe Moreau; Cyrille Hulin; Alexis Talbot; Hélène Demarquette; Léo Caillot; Thomas Chalopin; Arthur Bobin; Salomon Manier; Xavier Leleu; Lionel Karlin; Denis Caillot; Cécile Sonntag; Pierre Feugier; Murielle Roussel; Romain Gounot; Margaret Macro; Mohamad Mohty; Laurent Garderet; Mourab Tiab; Frédérique Orsini-Piocelle; Laure Vincent; Nathalie Meuleman; Jean Fontan; Lidia Montes; Marie-Christiane Vekemans; Martine Escoffre-Barbe; Jean-Richard Eveillard; Jean-Marc Schiano de Colella; Jérôme Lambert; Jean-Yves Mary; Jean-Paul Fermand; Bertrand Arnulf; Jill Corre; Hervé Avet-Loiseau; Thierry Facon; Jean-Luc Harousseau; Cyrille Touzeau; Aurore Perrot
err分享
err收藏
Debulking strategy prior to anti-BCMA/CD3 bispecific antibodies in extramedullary and/or high tumor burden RRMM: a retrospective cohort study减瘤策略在髓外和/或高肿瘤负荷RRMM患者接受抗BCMA/CD3双特异性抗体治疗前：一项回顾性队列研究
errBlood Cancer Journal
IF11.6
err2025-10-21
err0
errOAAI
errThomas Chalopin; Elise Cellerin; Hélène Demarquette; Andréa Pieragostini; Cécile Sonntag; Caroline Jaquet; Zoé De Wyngaert; Anne Rumpler; Murielle Roussel; Gaelle Labouré; Véronique Morel; Laure Vincent; Valéry Salle; Titouan Cazaubiel; Arthur Bobin; Anaïs Schavgoulidze; Jill Corre; Xavier Leleu; Salomon Manier
err分享
err收藏
Safety and efficacy of a dexamethasone-sparing regimen with daratumumab and lenalidomide in patients with frailty and newly diagnosed multiple myeloma (IFM2017-03): a phase 3, open-label, multicentre, randomised, controlled trial脆弱及新诊断多发性骨髓瘤患者中地塞米松减量方案联合达拉珠单抗和来那度胺的安全性与有效性（IFM2017-03）：一项III期、开放标签、多中心、随机对照试验
errThe Lancet Oncology
IF0
err2025-09-29
err0
errOAAI
errSalomon Manier; Jérôme Lambert; Cyrille Hulin; Margaret Macro; Kamel Laribi; Carla Araujo; Gian Matteo Pica; Cyrille Touzeau; Pascal Godmer; Borhane Slama; Lionel Karlin; Frédéric Orsini Piocelle; Mamoun Dib; Laurence Sanhes; Pierre Morel; Abderazzak El Yamani; Mourad Tiab; Reza Tabrizi; Valentine Richez; Laurent Garderet; Bruno Royer; Benoit Bareau; Clara Mariette; Emmanuel Fleck; Daniela Robu; Claire Calmettes; Sophie Rigaudeau; Hélène Demarquette; Laurent Frenzel; Olivier Decaux; Mohamad Mohty; Bertrand Arnulf; Noémie Bigot; Aurore Perrot; Jill Corre; Jean-Yves Mary; Hervé Avet-Loiseau; Philippe Moreau; Xavier Leleu; Thierry Facon
err分享
err收藏
Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trialCASSIOPEIA试验中，新诊断多发性骨髓瘤患者维持治疗前的FDG PET/CT反应的预后价值
errBlood
IF23.1
err2025-09-26
err0
PREAI
errFrançoise Kraeber-Bodéré; Bastien Jamet; Sonja Zweegman; Aurore Perrot; Cyrille Hulin; Denis Caillot; Thierry Facon; Xavier Leleu; Karim Belhadj; Emmanuel Itti; Lionel Karlin; Clément Bailly; Mark-David Levin; Monique C. Minnema; Caroline Bodet-Milin; Bart de Keizer; Jill Corre; Pieter Sonneveld; Philippe Moreau; Thomas Carlier; Cyrille Touzeau
err分享
err收藏
High-risk genomic consensus validation in newly diagnosed multiple myeloma patients using next-generation sequencing使用下一代测序对 newly diagnosed multiple myeloma 患者进行高风险基因组共识验证
errBlood
IF23.1
err2025-09-26
err0
PREAI
errAnaïs Schavgoulidze; Aurore Perrot; Xavier Leleu; Titouan Cazaubiel; Marie-Lorraine Chretien; Pierre Feugier; Karim Belhadj; Salomon Manier; Murielle Roussel; Sabine Brechignac; Frédérique Orsini-Piocelle; Mohamad Mohty; Jean-Marc Schiano de Collela; Margaret Macro; Didier Adiko; Mamoun Dib; Jean Fontan; Carine Luttiau-Motard; Didier Bouscary; Laurent Pascal; Virginie Roland; François Lifermann; Jana Bakala; Lydia Montes; Céline Kennel; Philippe Rey; Valentine Richez; Faiza Keddar; Laurent Frenzel; Claire Calmettes; Carine Chaleteix; Isabelle Plantier; Emilie Chalayer; Anna Schmitt; Christophe Roul; Hélène Demarquette; Chloe Cerutti; Luka Pavageau; Laure Derrier; Hervé Avet-Loiseau; Jill Corre
err分享
err收藏
Poor Outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study从ide-cel早期复发后使用靶向BCMA的双特异性抗体治疗效果不佳：一项法国真实世界研究
errBlood Advances
IF7.1
err2025-09-20
err0
errOAAI
errSarah Cayla; Lionel Karlin; Jérôme Lambert; Anne Lazareth; Alexis Talbot; Mohamad Mohty; Florent Malard; Marie-Odile Petillon; Salomon Manier; Ibrahim Yakoub-Agha; Denis Caillot; Ingrid Lafon; Xavier Leleu; Niels Moya; Bruno Royer; Jean-Marc Schiano De Colella; Gabriel Brisou; Cyrille Touzeau; Aurore Perrot; Pierre Bories; Laure Vincent; Hanane Guedon; Olivier Decaux; Benoît Ferment; Roch Houot; Steven Le Gouill; Noémie Bigot; Thierry Facon; Jill Corre; Hervé Avet-Loiseau; Philippe Moreau; Bertrand Arnulf
err分享
err收藏
Risk of synchronous and second primary malignancies in multiple myeloma transplant-ineligible treated with lenalidomide接受来那度胺治疗的非移植适应证多发性骨髓瘤患者中，同步及第二原发恶性肿瘤的风险
errBlood Advances
IF7.1
err2025-08-28
err0
errOAAI
errThomas SYSTCHENKO; Laly NSIALA; Arthur BOBIN; Hélène GARDENEY; Carine MOTARD; Gaelle OLIVIER; Florence BORDE; Anne CORBY; Christophe ROUL; Emmanuel FLECK; Guillaume DENIS; Céline DIEVAL; Philippe MOTTAZ; Annick BOSCAGLI; Gautier DEFOSSEZ; Xavier LELEU
err分享
err收藏
Comparative Effectiveness of Ciltacabtagene Autoleucel in CARTITUDE-4 Versus Real-World Physician’s Choice of Therapy from the Flatiron Registry in Lenalidomide-Refractory Multiple MyelomaCiltacabtagene autoleucel在CARTITUDE-4研究中的比较有效性，与来自Flatiron登记研究中来那度胺难治性多发性骨髓瘤的真实世界医生选择疗法进行比较
errAdvances in Therapy
IF4
err2025-08-06
err0
errOAAI
errCyrille Touzeau; Brea Lipe; Abdullah M. Khan; Binod Dhakal; Sandhya Nair; Jianming He; João Mendes; Seina Lee; Carolina Lonardi; Ana Slaughter; Nikoletta Lendvai; Jordan M. Schecter; Diana Chen; Man Zhao; Tzu-min Yeh; Xavier Leleu; Noemí Puig; Dominik Dytfeld; Elena Zamagni; Katja Weisel; Lionel Karlin; Michel Delforge; Paolo Corradini; Roberto Mina; Wilfried Roeloffzen; Surbhi Sidana
err分享
err收藏
Practical Guidance on Clinical Management of Belantamab Mafodotin-Associated Ocular EventsBelantamab Mafodotin相关眼部事件的临床管理实用指南
errAmerican Journal of Hematology
IF9.9
err2025-07-28
err0
errOAAI
errEvangelos Terpos; Suzanne Trudel; María-Victoria Mateos; Nicolás Alejandre; Kathryn Colby; Meletios A. Dimopoulos; Simona Degli Esposti; Asim V. Farooq; Maria Gavriatopoulou; Francesca Gay; Vania Hungria; K. Martin Kortüm; Xavier Leleu; Sagar Lonial; Hang Quach; Lugui Qiu; Karthik Ramasamy; Kazuhito Suzuki; Katja C. Weisel; Paul Richardson
err分享
err收藏
Isatuximab for the treatment of multiple myeloma: current clinical advances and future directionsIsatuximab在多发性骨髓瘤治疗中的应用：当前临床进展与未来方向
errExpert Opinion on Investigational Drugs
IF4.1
err2025-07-23
err0
errOAAI
errPaul G. Richardson; Elisabeth K. O’Donnell; Peter O’Gorman; Lisa B. Leypoldt; Jacob Laubach; Francesca Gay; Xavier Leleu; Thierry Facon; Philippe Moreau; Meletios A. Dimopoulos; Hartmut Goldschmidt; Elias K. Mai; Michele Cavo; Katja C. Weisel; Jesus G. Berdeja; Robert Z. Orlowski; Meral Beksaç; Aurore Perrot; Joseph Mikhael; Thomas Martin
err分享
err收藏
Thromboembolism in transplant-ineligible multiple myeloma patients on triplet/quadruplet therapy: a post-hoc analysis of BENEFIT移植不适格的套细胞瘤患者在使用三联/四联疗法时的血栓栓塞：BENEFIT研究的后续分析
errJournal of Thrombosis and Haemostasis
IF5
err2025-06-14
err0
PREAI
errEmilie Chalayer; Corinne Frere; Elisabeth Daguenet; Thomas Lecompte; Bernard Tardy; Ilhame Bounouara; Manon Sapet; Arthur Bobin; Stephanie Harel; Olivier Decaux; Karim Belhadj; Cyrille Touzeau; Margaret Macro; Mohamad Mohty; Philippe Moreau; Jill Corre; Hervé Avet–Loiseau; Lionel Karlin; Thierry Facon; Aurore Perrot; Cyrille Hulin; Salomon Manier; Laurent Frenzel; Xavier Leleu
err分享
err收藏
Comparative Efficacy of Ciltacabtagene Autoleucel Versus Standard-of-Care Treatments for Patients with Previously Treated Relapsed or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Comparison比较cilta-cabtagene autoleucel与标准护理治疗用于既往接受过治疗的复发或难治性多发性骨髓瘤患者的疗效：一项匹配调整间接比较研究
errADVANCES IN THERAPY
IF4
err2025-05-12
err0
errOAAI
errPuig, N; Diels, J; van Sanden, S; Mendes, J; Burnett, H; Cichewicz, A; Lee, S; Hernando, T; Schecter, JM; Lendvai, N; Patel, N; Sanchez-Pina, JM; Rocchi, S; Mina, R; Corradini, P; Cavo, M; Miguel, JS; Shune, L; Khan, AM; Sidana, S; Leleu, X; Manier, S; Lipe, B; Weisel, K; Martinez-Lopez, J
err分享
err收藏
Time for a paradigm shift in immunotherapy-based BCMA/CD3 bispecific drug development in multiple myeloma是时候对基于免疫疗法的BCMA/CD3双特异性药物在多发性骨髓瘤中的开发进行范式转变了。
errLEUKEMIA
IF13.4
err2025-04-24
err0
PREAI
errLeleu, Xavier; Bobin, Arthur; Herbelin, Andre; Gombert, Jean-Marc; Rajkumar, S. Vincent
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
K
Kenneth C. Anderson
H 指数: 199 · 论文数: 3.1K
P
Paul G. Richardson
H 指数: 170 · 论文数: 2.1K
S
S. Vincent Rajkumar
H 指数: 165 · 论文数: 1.9K
P
Philippe Moreau
H 指数: 159 · 论文数: 2.3K
M
Meletios Α. Dimopoulos
H 指数: 159 · 论文数: 3.0K
查看更多